EUVIMEDEUVIMED entdecken
Crossref

Natural ERRα Activator Formononetin Ameliorates Anthracycline Cardiotoxicity via Metabolic Improvement

Xiaoping Wang iD, Guanjing Ling, Yan Wei, Weili Li iD, Yi Zhang iD, Ziyi Yin iD, Kai Wei, Qian Chen iD, Lei Dong, Yun Chen, Wei Wang, Qi Qiu und 1 weitere

Circulation Research · 11.09.2026 · 139 (7)

DOI: 10.1161/circresaha.126.329042 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Circulation Research, erschienen am 11.09.2026. Verfasst von Xiaoping Wang und 12 weiteren Autor:innen. Beteiligte Einrichtung: School of Chinese Medicine, Beijing University of Chinese Medicine (X.W., G.L., Y. Wei, W.L., Y.C., W.W., Y. Wang). Hauptthemen laut MEDLINE: Isoflavones, Receptors, Estrogen, Myocytes, Cardiac, Anthracyclines. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 45 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Anthracycline-induced cardiotoxicity (AIC) limits life-saving chemotherapy and is driven by early metabolic remodeling. The nuclear receptor ERRα (estrogen-related receptor α) is a master regulator of cardiac energy metabolism, but the temporal dynamics of its downregulation, its causal role in AIC pathogenesis, and whether it can be pharmacologically activated to confer protection remain undefined. METHODS: We performed temporal protein analysis in a porcine AIC model. Using cardiomyocyte-specificgain- and loss-of-function mouse models, we assessed the causal role of ERRα. Mechanistic studies included ChIP-qPCR, reporter assays, and microscale thermophoresis to investigate the natural compound formononetin. Human breast cancer patient-derived organoids were used to evaluate anticancer activity. RESULTS: ERRα expression was selectively downregulated in AIC pig hearts and cardiac tissue from chemotherapy-treated patients. Temporal analysis in pigs revealed that ERRα reduction occurred at the subclinical (6-week) stage, preceding overt cardiac dysfunction. Cardiomyocyte-specific ERRα overexpression activated mitochondrial gene programs, enhanced fatty acid oxidation, and preserved systolic function after doxorubicin challenge, whereas ERRα knockdown exacerbated bioenergetic failure and cardiac dysfunction. Through drug screening, we identified formononetin as a potent and selective ERRα agonist. Formononetin enhanced ERRα transcriptional activity, improved mitochondrial metabolism, and protected against AIC in both murine and porcine models. Mechanistically, ChIP-qPCR demonstrated increased ERRα occupancy at target gene promoters, and microscale thermophoresis confirmed direct binding of formononetin to the ERRα/PGC-1α (peroxisome proliferator-activated receptor γ coactivator-1α) complex, indicating allosteric stabilization. Finally, in human breast cancer patient-derived organoids, formononetin alone reduced viability and proliferation, and combined with doxorubicin further enhanced antitumor efficacy. CONCLUSIONS: ERRα downregulation is a causal early event in the pathogenesis of AIC. Formononetin acts as a first-in-class selective ERRα activator that improves cardiac metabolism and function while retaining anticancer activity, supporting its potential as a dual-action cardioprotective agent during anthracycline therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

IsoflavonesReceptors, EstrogenMyocytes, CardiacAnthracyclinesEnergy MetabolismAntibiotics, AntineoplasticAnimalsERRalpha Estrogen-Related ReceptorHumansCardiotoxicityFemaleMiceSwineDoxorubicinMice, KnockoutBreast Neoplasms

Stichwörter der Autor:innen

anthracyclinescardiotoxicityfatty acidsorganoids

Substanzen

IsoflavonesERRalpha Estrogen-Related ReceptorReceptors, EstrogenformononetinAnthracyclinesDoxorubicinAntibiotics, Antineoplastic

Autor:innen und Institutionen

  • School of Chinese Medicine, Beijing University of Chinese Medicine (X.W., G.L., Y. Wei, W.L., Y.C., W.W., Y. Wang).
  • Institute of Basic Medical Sciences & School of Basic Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing (X.W., Z.Y., Q.C.).
  • Beijing Diabetes Institute, Department of Endocrinology, Beijing Tongren Hospital, Capital Medical University, China (Y.Z.).
  • School of Life Sciences, Beijing University of Chinese Medicine, China (K.W.).
  • Department of Breast Disease, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing (L.D.).
  • Department of Pharmacy, Beijing Anzhen Hospital, Capital Medical University, China (Q.Q.).

ORCID-Profile: Xiaoping Wang, Weili Li, Yi Zhang, Ziyi Yin, Qian Chen, Yong Wang

Zitieren

APA

Wang, X., Ling, G., Wei, Y., Li, W., Zhang, Y., Yin, Z., Wei, K., Chen, Q., Dong, L., Chen, Y., Wang, W., Qiu, Q., & Wang, Y. (2026). Natural ERRα Activator Formononetin Ameliorates Anthracycline Cardiotoxicity via Metabolic Improvement. Circulation Research, 139(7). https://doi.org/10.1161/circresaha.126.329042

Vancouver

Wang X, Ling G, Wei Y, Li W, Zhang Y, Yin Z, et al. Natural ERRα Activator Formononetin Ameliorates Anthracycline Cardiotoxicity via Metabolic Improvement. Circulation Research. 2026;139(7). doi:10.1161/circresaha.126.329042

BibTeX
@article{Wang2026,
  author = {Wang, Xiaoping and Ling, Guanjing and Wei, Yan and Li, Weili and Zhang, Yi and Yin, Ziyi and Wei, Kai and Chen, Qian and Dong, Lei and Chen, Yun and Wang, Wei and Qiu, Qi and Wang, Yong},
  title = {Natural ERRα Activator Formononetin Ameliorates Anthracycline Cardiotoxicity via Metabolic Improvement},
  journal = {Circulation Research},
  year = {2026},
  volume = {139},
  number = {7},
  doi = {10.1161/circresaha.126.329042}
}
Kostenlos starten →